PNC Financial Services Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.9K | Sell |
13,031
-198
| -1% | -$1K | ﹤0.01% | 2961 |
|
|
2025
Q1 | $70K | Buy |
13,229
+3,409
| +35% | +$18K | ﹤0.01% | 2897 |
|
|
2024
Q4 | $66.4K | Buy |
9,820
+6,758
| +221% | +$45.7K | ﹤0.01% | 2926 |
|
|
2024
Q3 | $20.2K | Sell |
3,062
-23
| -0.7% | -$152 | ﹤0.01% | 3502 |
|
|
2024
Q2 | $23.1K | Buy |
3,085
+846
| +38% | +$6.35K | ﹤0.01% | 3407 |
|
|
2024
Q1 | $22.3K | Buy |
2,239
+176
| +9% | +$1.76K | ﹤0.01% | 3397 |
|
|
2023
Q4 | $20.3K | Buy |
2,063
+94
| +5% | +$927 | ﹤0.01% | 3421 |
|
|
2023
Q3 | $15.1K | Hold |
1,969
| – | – | ﹤0.01% | 3580 |
|
|
2023
Q2 | $14.7K | Buy |
+1,969
| New | +$14.7K | ﹤0.01% | 3696 |
|